Hikma launches generic Xeloda in the US

Hikma Pharmaceuticals announced yesterday that its US affiliate West-Ward Pharmaceuticals, has launched a generic version of Genentech’s cancer treatment drug Xeloda (capecitabine) in the US.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Africa

Hikma and Vectura collaborate to develop GSK generics

12 November 2018 Jordan-based Hikma Pharmaceuticals and British pharmaceutical company Vectura Group have united to develop generic versions of GSK’s Ellipta respiratory products.

Generics

Hikma ‘skinny’ label does not infringe Amarin patents

6 January 2022 Hikma Pharmaceuticals has secured a win in its “skinny label” patent suit with Amarin Pharmaceuticals, following a ruling handed down by a federal court in the state of Delaware.

More on this story

Africa

Hikma and Vectura collaborate to develop GSK generics

12 November 2018 Jordan-based Hikma Pharmaceuticals and British pharmaceutical company Vectura Group have united to develop generic versions of GSK’s Ellipta respiratory products.

Generics

Hikma ‘skinny’ label does not infringe Amarin patents

6 January 2022 Hikma Pharmaceuticals has secured a win in its “skinny label” patent suit with Amarin Pharmaceuticals, following a ruling handed down by a federal court in the state of Delaware.

More on this story

Africa

Hikma and Vectura collaborate to develop GSK generics

12 November 2018 Jordan-based Hikma Pharmaceuticals and British pharmaceutical company Vectura Group have united to develop generic versions of GSK’s Ellipta respiratory products.

Generics

Hikma ‘skinny’ label does not infringe Amarin patents

6 January 2022 Hikma Pharmaceuticals has secured a win in its “skinny label” patent suit with Amarin Pharmaceuticals, following a ruling handed down by a federal court in the state of Delaware.

More features

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

Sandoz wins $137.2m payout for lost profits in generic launch

Sanofi signs global rights deal to develop rare cancer therapy

Unified Patent Court visualised: Cases, divisions, and classes in charts

WBD to merge with firm to create ‘powerhouse’ practice

‘Be prepared, and don’t assume at the UPC’: Christopher Stothers

Hikma launches generic Xeloda in the US

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features